TAVERAS ARTHUR (Chief Scientific Officer) sold 0.3% of their position (787.00 shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $792.67 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2024ACC: 0001628280-24-004287
Officer· Chief Scientific Officer
Since Nov 2020
-787.00
Net shares
Net seller
$792.67
Total sold
1
Open market trades
0B · 1S
1
Total transactions
787.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−787.00
Price / share
$1.01
Trade value
$792.67
% of position
0.3%
2/12/2024
249.32K→248.54K
Total
Net shares
−787.00
Net value
-$792.67
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2024 | S · Sale | −787.00 | $1.01 | $792.67 | 0.3% | 249.32K | 248.54K |
| Total | −787.00 | -$792.67 | ||||||
Derivative Transactions0
No derivative transactions reported